Interfacial interactions between protective, surface-engineered shells and encapsulated bacteria with different cell surface composition
Open Access
- 31 March 2021
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 13 (15) , 7220-7233
Abstract
Surface-engineered encapsulation is a non-genetic method to protect living organisms against harsh environmental conditions. Different cell encapsulation methods exist, yielding shells with different interfacial-interactions with encapsulated, bacterial surfaces. However, the impact of interfacial-interactions on the protection offered by different shells is unclear and can vary for bacteria with different surface composition. Probiotic bacteria require protection against gastro-intestinal fluids and antibiotics. Here, we encapsulated two probiotic strains using ZIF-8 (zeolitic imidazolate framework) biomineralization (strong-interaction by coordinate–covalent bonding), alginate gelation (intermediate-interaction by hydrogen bonding) or protamine-assisted packing of SiO2 nanoparticles yielding a yolk–shell (weak-interaction across a void between shells and bacterial surfaces). The surface of probiotic Lactobacillus acidophilus was rich in protein, yielding a hydrophilic, positively-charged surface below and a negatively-charged one above pH 4.0. Probiotic Bifidobacterium infantis had a hydrophilic, uncharged surface, rich in polysaccharides with little proteins. Although amino groups are required for coordinate–covalent bonding of zinc and hydrogen bonding of alginate, both L. acidophilus and B. infantis could be encapsulated using ZIF-8 biomineralization and alginate gelation. Weakly, intermediately and strongly interacting shells all yielded porous shells. The strongly interacting ZIF-8 biomineralized shell made encapsulated bacteria more susceptible to antibiotics, presumably due to the cell wall damage already inflicted during Zif-8 biomineralization. Overall, weakly interacting yolk–shells and intermediately interacting alginate gels protected best and maintained probiotic activity of encapsulated bacteria. The impact of interfacial-interactions between shells and encapsulated bacteria on different aspect of protection described here, contributes to the further development of effective surface-engineered shells and its application for protecting bacteria.Keywords
Funding Information
- Universitair Medisch Centrum Groningen
- National Natural Science Foundation of China (52002414)
- Fundamental Research Funds for the Central Universities (19lgzd16)
- Fundamental Research Funds for the Central Universities (19lgpy112)
This publication has 43 references indexed in Scilit:
- Microbiota restoration: natural and supplemented recovery of human microbial communitiesNature Reviews Microbiology, 2010
- Importance of intermolecular interaction on the improvement of intestinal therapeutic peptide/protein absorption using cell-penetrating peptidesJournal of Controlled Release, 2009
- Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trialBMJ, 2007
- Surface characterization of the Gram‐positive bacteria Bacillus subtilis ‐an XPS studySurface and Interface Analysis, 2006
- Deposition of CTAB-Terminated Nanorods on Bacteria to Form Highly Conducting Hybrid SystemsJournal of the American Chemical Society, 2005
- Electric double layer interactions in bacterial adhesion to surfacesSurface Science Reports, 2002
- Theoretical Studies of Metal Ion Selectivity. 1. DFT Calculations of Interaction Energies of Amino Acid Side Chains with Selected Transition Metal Ions (Co2+, Ni2+, Cu2+, Zn2+, Cd2+, and Hg2+)Journal of the American Chemical Society, 2000
- X-ray photoelectron spectroscopy for the study of microbial cell surfacesSurface Science Reports, 2000
- Surface of Lactic Acid Bacteria: Relationships between Chemical Composition and Physicochemical PropertiesApplied and Environmental Microbiology, 2000
- Mechanisms and Management of Antibiotic‐Associated DiarrheaClinical Infectious Diseases, 1998